Elevated Serum Carboxymethyl-Lysine, an Advanced Glycation End Product, Predicts Severe Walking Disability in Older Women: The Women's Health and Aging Study I
Advanced glycation end products (AGEs) have been implicated in the pathogenesis of sarcopenia. Our aim was to characterize the relationship between serum carboxymethyl-lysine (CML), a major circulating AGE, and incident severe walking disability (inability to walk or walking speed <0.4 m/sec) ove...
Saved in:
Main Authors: | Kai Sun, Richard D. Semba, Linda P. Fried, Debra A. Schaumberg, Luigi Ferrucci, Ravi Varadhan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Journal of Aging Research |
Online Access: | http://dx.doi.org/10.1155/2012/586385 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of oxidation and precursors (lysine, glyoxal and Schiff base) on the formation of Nε-carboxymethyl-lysine in aged, stored and thermally treated chicken meat
by: Suhong Huang, et al.
Published: (2022-09-01) -
Effect of exogenous free Nε-(carboxymethyl)lysine on diabetes-associated cognitive dysfunction: neuroinflammation, and metabolic disorders
by: Huang Zhang, et al.
Published: (2024-09-01) -
Nε-Carboxymethyl-Lysine Negatively Regulates Foam Cell Migration via the Vav1/Rac1 Pathway
by: Zhengyang Bao, et al.
Published: (2020-01-01) -
The associations between dietary advanced glycation-end products intake and self-reported infertility in U.S. women: data from the NHANES 2013–2018
by: Lingxia Tong, et al.
Published: (2025-01-01) -
Role of Advanced Glycation End Products in Mediating Glycated Haemoglobin and Pulse Wave Velocity in Healthy Adults
by: Irene Martínez-García, et al.
Published: (2025-01-01)